Nalu Bio
PrivateLast Round
Series A
Feb 28, 2023
Total Funding Raised
$12M
Company Overview
Nalu Bio is a biotechnology company that has developed a drug discovery platform to accelerate the development of prescription and nonprescription health products targeting the endocannabinoid system (ECS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Sustainable Materials, Medical AI
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nalu Bio Comps
Public and private peers based on sector, stage, and business model.
Nalu Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 28, 2023 | ||||
| Seed | Jan 7, 2021 |
Nalu Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Intrinsic Capital Partners | Series A |
| Bonaventure Equity | Series A, Seed |
| Brown Angel Group | Series A |
| XFactor Ventures | Seed |
| Sacramento Angels | Series A |
| L37 Ventures | Series A, Seed |
| Golden Seeds | Series A, Seed |
Nalu Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nalu Bio's valuation, stock price, and market status.
